|

Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance

RECRUITINGSponsored by Universal Diagnostics
Actively Recruiting
SponsorUniversal Diagnostics
Started2023-07-31
Est. completion2026-12-31
Eligibility
Age45 Years – 84 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07310446

Summary

This study is designed to prospectively collect blood samples and clinical data from patients that have been newly diagnosed with colorectal cancer and scheduled for resection surgery but are pre cancer treatment, subjects who are NOT scheduled for surgery but have histological confirmation of CRC from the diagnostic colonoscopy and clinical staging (cTMN) is available and are pr e- treatment, and patients who are at average risk of colorectal cancer and who are scheduled for routine colonoscopy examinations.

Eligibility

Age: 45 Years – 84 YearsHealthy volunteers accepted
Inclusion Criteria:

* Arm A: Diagnosed with CRC
* Arm B: Undergoing screening with colonoscopy for CRC

Exclusion Criteria:

* Arm A: Undergoing treatment for CRC,
* Arm B: Past history of CRC

Conditions2

CancerColorectal Cancer

Locations1 site

Gastroenterology and Internal Medicine Specialists
Lake Barrington, Illinois, 60010
Manish Bhuva, MD8473824410prove@universaldx.com

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.